Wednesday, HOOKIPA Pharma Inc (NASDAQ:HOOK) received clearance from the FDA for its Investigational New Drug (IND) application for HB-700, a novel arenaviral therapeutic vaccine for the treatment of KRAS-mutated cancers. In January, Roche terminated the collaboration and licensing agreement for HOOKIPA’s HB-700 program in KRAS mutated cancers. HOOKIPA’s HB-700 program is designed to treat KRAS-mutated lung, colorectal, pancreatic, and other cancers by targeting the five most prevalent KRAS mutat
The United States in recent weeks secretly shipped long-range missiles to Ukraine for use in its battle to fight off Russian invaders, and Ukraine last week used them for the first time, a U.S. official said on Wednesday. The missiles were contained in a $300 million military aid package for Ukraine that U.S. President Joe Biden approved on March 12, said the U.S. official, speaking on condition of anonymity.
What are your predictions for the looming contest between the Boston Celtics and Miami Heat in Game 2?